https://www.selleckchem.com/products/cc-115.html
Immunotherapy is increasingly defining a role in a wide variety of tumours such that as use becomes more ubiquitous, so too will the complications. A relatively rare complication of immunotherapy use is immune-related gastritis. In this case series, we present two cases of immunotherapy-related gastritis from our institution and undertake a comprehensive review and analysis of the literature around this less common adverse event. Immune checkpoint inhibitors (ICIs) are currently the standard of care for metastatic urothelial cancer (mUC)
Like
Comment
Share
